A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells

被引:21
|
作者
Yamamoto, Keita [1 ]
Goyama, Susumu [1 ]
Asada, Shuhei [1 ,2 ]
Fujino, Takeshi [1 ]
Yonezawa, Taishi [1 ]
Sato, Naru [1 ]
Takeda, Reina [1 ]
Tsuchiya, Akiho [1 ]
Fukuyama, Tomofusa [1 ]
Tanaka, Yosuke [1 ]
Yokoyama, Akihiko [3 ]
Toya, Hikaru [4 ]
Kon, Ayana [5 ]
Nannya, Yasuhito [5 ]
Onoguchi-Mizutani, Rena [6 ]
Nakagawa, Shinichi [4 ]
Hirose, Tetsuro [7 ]
Ogawa, Seishi [5 ]
Akimitsu, Nobuyoshi [6 ]
Kitamura, Toshio [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Lab Anim, Tokyo, Japan
[3] Natl Canc Ctr, Tsuruoka Metabol Lab, Yamagata, Japan
[4] Hokkaido Univ, Fac Pharmaceut Sci, RNA Biol Lab, Sapporo, Hokkaido, Japan
[5] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan
[6] Univ Tokyo, Isotope Sci Ctr, Tokyo, Japan
[7] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan
来源
CELL REPORTS | 2021年 / 36卷 / 08期
基金
日本学术振兴会;
关键词
LONG NONCODING RNA; MYELODYSPLASTIC SYNDROMES; PROTEIN; GENE; EXPRESSION; NEAT1; POLYCOMB; TRANSFORMATION; EPIGENETICS; STABILITY;
D O I
10.1016/j.celrep.2021.109576
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Paraspeckles are membraneless organelles formed through liquid-liquid phase separation and consist of multiple proteins and RNAs, including NONO, SFPQ, and NEAT1. The role of paraspeckles and the component NONO in hematopoiesis remains unknown. In this study, we show histone modifier ASXL1 is involved in paraspeckle formation. ASXL1 forms phase-separated droplets, upregulates NEAT1 expression, and increases NONO-NEAT1 interactions through the C-terminal intrinsically disordered region (IDR). In contrast, a pathogenic ASXL mutant (ASXL1-MT) lacking IDR does not support the interaction of paraspeckle components. Furthermore, paraspeckles are disrupted and Nono localization is abnormal in the cytoplasm of hematopoietic stem and progenitor cells (HSPCs) derived from ASXL1-MT knockin mice. Nono depletion and the forced expression of cytoplasmic NONO impair the repopulating potential of HSPCs, as does ASXL1MT. Our study indicates a link between ASXL1 and paraspeckle components in the maintenance of normal hematopoiesis.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] ASXL1 is involved in paraspeckle formation in hematopoietic cells
    Yamamoto, Keita
    Kitamura, Toshio
    Goyama, Susumu
    CANCER SCIENCE, 2023, 114 : 721 - 721
  • [2] Mutant ASXL1 Disrupts Paraspeckle Formation through Aberrant Interaction with Nono in Hematopoietic Cells
    Keita, Yamamoto
    Goyama, Susumu
    Asada, Shuhei
    Fujino, Takeshi
    Fukuyama, Tomofusa
    Tanaka, Yosuke
    Kon, Ayana
    Nannya, Yasuhito
    Ogawa, Seishi
    Onoguchi, Reina
    Akimitsu, Nobuyoshi
    Kitamura, Toshio
    BLOOD, 2019, 134
  • [3] EPIGENETIC REGULATOR ASXL1 PROMOTES PARASPECKLE FORMATION THROUGH C-TERMINAL INTRINSICALLY DISORDERED REGION IN HEMATOPOIETIC CELLS
    Yamamoto, Keita
    Goyama, Susumu
    Yonezawa, Taishi
    Asada, Shuhei
    Fujino, Tsuyosho
    Fukuyama, Tomofusa
    Tanaka, Yousuke
    Kitamura, Toshio
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S85 - S85
  • [4] Loss of ASXL1 triggers an apoptotic response in human hematopoietic stem and progenitor cells
    Hilgendorf, Susan
    Folkerts, Hendrik
    Schuringa, Jan Jacob
    Vellenga, Edo
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (12) : 1188 - 1196
  • [5] Loss of ASXL1 Triggers an Apoptotic Response in Human Hematopoietic Stem and Progenitor Cells
    Hilgendorf, Susan
    Folkerts, Hendrik
    Schuringa, Jan Jacob
    Vellenga, Edo
    BLOOD, 2015, 126 (23)
  • [6] Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
    Asada, Shuhei
    Kitamura, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (02) : 179 - 186
  • [7] Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
    Shuhei Asada
    Toshio Kitamura
    International Journal of Hematology, 2019, 110 : 179 - 186
  • [8] Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations
    Inoue, Daichi
    Kitaura, Jiro
    Togami, Katsuhiro
    Nishimura, Koutarou
    Enomoto, Yutaka
    Uchida, Tomoyuki
    Kagiyama, Yuki
    Kawabata, Kimihito Cojin
    Nakahara, Fumio
    Izawa, Kumi
    Oki, Toshihiko
    Maehara, Akie
    Isobe, Masamichi
    Tsuchiya, Akiho
    Harada, Yuka
    Harada, Hironori
    Ochiya, Takahiro
    Aburatani, Hiroyuki
    Kimura, Hiroshi
    Thol, Felicitas
    Heuser, Michael
    Levine, Ross L.
    Abdel-Wahab, Omar
    Kitamura, Toshio
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11): : 4627 - 4640
  • [9] MUTANT ASXL1 INDUCES EXPANSION OF HEMATOPOIETIC STEM CELLS THROUGH ACTIVATION OF AKT/MTOR PATHWAY
    Fujino, Takeshi
    Goyama, Susumu
    Sugiura, Yuki
    Inoue, Daichi
    Asada, Shuhei
    Yamasaki, Satoshi
    Matsumoto, Akiko
    Tsuchiya, Akiho
    Shikata, Shiori
    Sato, Naru
    Morinaga, Hironobu
    Fukuyama, Tomofusa
    Tanaka, Yosuke
    Fukushima, Tsuyoshi
    Takeda, Reina
    Yamamoto, Keita
    Honda, Hiroaki
    Nishimura, Emi
    Shibata, Tatsuhiro
    Abdel-Wahab, Omar
    Suematsu, Makoto
    Kitamura, Toshio
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S41 - S41
  • [10] CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING
    Valletta, S.
    Dolatshad, H.
    Bello, E.
    Yip, B. H.
    Bartenstein, M.
    Gordon, S.
    Shaw, J.
    Roy, S.
    Scifo, L.
    Pellagatti, A.
    Fulga, T. A.
    Verm, A.
    Boultwood, J.
    HAEMATOLOGICA, 2015, 100 : 169 - 169